Opioid manufacturers gained ground in a massive legal battle as a second court rejected claims that marketing of pain medications constitutes a public nuisance. The ruling may help opioid makers reach long-sought global settlements to resolve thousands of suits.
In a 9 November ruling, the Supreme Court of the State of Oklahoma reversed a district court judgement that...







